Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.

about

Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.

Item

http://www.wikidata.org/entity/Q55488297

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Vonoprazan-based triple therap ...... licobacter pylori eradication.

@en

Vonoprazan-based triple therap ...... licobacter pylori eradication.

@nl

type

Item

label

Vonoprazan-based triple therap ...... licobacter pylori eradication.

@en

Vonoprazan-based triple therap ...... licobacter pylori eradication.

@nl

prefLabel

Vonoprazan-based triple therap ...... licobacter pylori eradication.

@en

Vonoprazan-based triple therap ...... licobacter pylori eradication.

@nl

P1476

Vonoprazan-based triple therap ...... elicobacter pylori eradication

@en

P2093

Akiei Ishizuka

http://www.w3.org/2001/XMLSchema#string

Eiichiro Ichiishi

http://www.w3.org/2001/XMLSchema#string

Hiroki Tanabe

http://www.w3.org/2001/XMLSchema#string

Katsuhisa Ohta

http://www.w3.org/2001/XMLSchema#string

Katsuyoshi Ando

http://www.w3.org/2001/XMLSchema#string

Keiichi Yoshino

http://www.w3.org/2001/XMLSchema#string

Kiichi Satoh

http://www.w3.org/2001/XMLSchema#string

Mikihiro Fujiya

http://www.w3.org/2001/XMLSchema#string

Takaaki Otake

http://www.w3.org/2001/XMLSchema#string

Yoshiki Nomura

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

P2888

s12941-018-0281-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12941-018-0281-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

T Okumura

P577

2018-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105169278

http://www.w3.org/2001/XMLSchema#string

P698

29950163

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

6022507

http://www.w3.org/2001/XMLSchema#string